TickerFactsScreenerDevelopers

Anika Therapeutics, Inc. (ANIK) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $3.96M2010: $2.78M2011: $1.40M2012: $1.50M2013: $441.0K2014: $1.55M2015: $9.22M2016: $14.01M2017: $8.98M2018: $4.66M2019: $2.83M2020: $1.63M2021: $5.14M2022: $7.49M2023: $5.43M2024: $7.73M2025: $6.83M$6.83M
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$6.83M-11.7%
2024$7.73M+42.5%
2023$5.43M-27.5%
2022$7.49M+45.6%
2021$5.14M+215.9%
2020$1.63M-42.4%
2019$2.83M-39.3%
2018$4.66M-48.2%
2017$8.98M-35.9%
2016$14.01M+51.9%
2015$9.22M+494.0%
2014$1.55M+252.2%
2013$441.0K-70.7%
2012$1.50M+7.5%
2011$1.40M-49.7%
2010$2.78M-29.7%
2009$3.96M—